Prevalence of problematic drug use in Martinique in 2006: The NEMO study.

IF 1.2 4区医学 Q4 NEUROSCIENCES Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique Pub Date : 2024-11-07 DOI:10.1016/j.encep.2024.09.002

Sloane Rollier, Thomas Lehoux, Bernard Angerville, Laure Vaissade, Jerome Lacoste, Sylvie Merle

{"title":"Prevalence of problematic drug use in Martinique in 2006: The NEMO study.","authors":"Sloane Rollier, Thomas Lehoux, Bernard Angerville, Laure Vaissade, Jerome Lacoste, Sylvie Merle","doi":"10.1016/j.encep.2024.09.002","DOIUrl":null,"url":null,"abstract":"Objectives: Substance use disorders are of worldwide public health interest. Local estimates of problematic drug use provide useful indicators to regional public health agencies in developing prevention and treatment programs. The purpose of the current study was to estimate the prevalence of problematic drug use in Martinique.Methods: The capture-recapture method was applied to a multisource data collection (eight specialized drug and two law enforcement sources) to provide an estimate of drug use (opiates, cocaine hydrochloride, crack (cocaine base), stimulants and/or hallucinogens). Data collection was organized over a period of six consecutive months (September 2005 to March 2006) and concerned all persons residing in Martinique longer than three months and who had consumed at least one of the studied drugs in the month prior to the study.Results: We identified 287 cases (86% male; mean age 36.1±9.6 years), 98% of whom had used crack. Comorbid use of illicit drugs other than alcohol and cannabis was 4%. Our study showed that patients with problematic drug use in Martinique is estimated to be 1.936 [95% CI: 964,2907] in a total population of 380.863 (INSEE, 1999). Prevalence rates were 5.0 per thousand among the global population and 7.7 per thousand in the adult population aged 15-64 years.Conclusions: Our study is the first to provide relevant data on the extent of problematic drug use in Martinique for health policies and decision-makers.","PeriodicalId":51042,"journal":{"name":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.encep.2024.09.002","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: Substance use disorders are of worldwide public health interest. Local estimates of problematic drug use provide useful indicators to regional public health agencies in developing prevention and treatment programs. The purpose of the current study was to estimate the prevalence of problematic drug use in Martinique.

Methods: The capture-recapture method was applied to a multisource data collection (eight specialized drug and two law enforcement sources) to provide an estimate of drug use (opiates, cocaine hydrochloride, crack (cocaine base), stimulants and/or hallucinogens). Data collection was organized over a period of six consecutive months (September 2005 to March 2006) and concerned all persons residing in Martinique longer than three months and who had consumed at least one of the studied drugs in the month prior to the study.

Results: We identified 287 cases (86% male; mean age 36.1±9.6 years), 98% of whom had used crack. Comorbid use of illicit drugs other than alcohol and cannabis was 4%. Our study showed that patients with problematic drug use in Martinique is estimated to be 1.936 [95% CI: 964,2907] in a total population of 380.863 (INSEE, 1999). Prevalence rates were 5.0 per thousand among the global population and 7.7 per thousand in the adult population aged 15-64 years.

Conclusions: Our study is the first to provide relevant data on the extent of problematic drug use in Martinique for health policies and decision-makers.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

2006 年马提尼克岛问题药物使用流行率：NEMO 研究。

目的：药物使用障碍是全球关注的公共卫生问题。当地对问题药物使用情况的估计为地区公共卫生机构制定预防和治疗计划提供了有用的指标。本研究旨在估算马提尼克岛问题药物使用的流行率：方法：采用捕获-再捕获法收集多源数据（八个专门的毒品数据源和两个执法数据源），以估算毒品使用情况（鸦片制剂、盐酸可卡因、快克（可卡因碱）、兴奋剂和/或致幻剂）。数据收集工作连续进行了六个月（2005 年 9 月至 2006 年 3 月），涉及所有在马提尼克岛居住三个月以上、在研究前一个月至少吸食过一种所研究药物的人：我们发现了287个病例（86%为男性；平均年龄（36.1±9.6）岁），其中98%使用过快克。除酒精和大麻外，合并使用其他非法药物的比例为 4%。我们的研究表明，马提尼克岛总人口为 380 863 人，其中问题药物使用患者估计为 1 936 人 [95% CI：964 2907]（国家统计和经济研究所，1999 年）。患病率在总人口中为 5.0‰，在 15-64 岁的成年人口中为 7.7‰：我们的研究首次为卫生政策和决策者提供了有关马提尼克岛问题药物使用程度的相关数据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Encephale-Revue De Psychiatrie Clinique Biologique et Therapeutique 医学-精神病学

CiteScore

4.60

自引率

7.40%

发文量

162

审稿时长

6-12 weeks

期刊介绍： Une revue française de renommée internationale. - Un comite de rédaction représentant tous les aspects de la prise en charge psychiatrique du patient. - Une sélection rigoureuse d''articles faisant l''objet de plusieurs expertises. - Des travaux d''auteurs et de chercheurs de renommée internationale. - Des indexations dans les grandes bases de données (Current Contents, Excerpta Medica, etc.). - Un facteur d''impact qui témoigne de la grande notoriété de la revue. La tribune des publications originales de haut niveau. - Une très grande diversité des sujets traités, rigoureusement sélectionnés à travers des sommaires dynamiques : - des éditoriaux de médecins référents, - une revue de presse sur les actualités internationales, - des articles originaux pour approfondir vos connaissances, - des mises au point et des cas cliniques pour engager votre réflexion sur les indications et choix possibles au travers de mises en situation clinique, - des dossiers thématiques pour faire le tour d''une question. - L''actualité de l''AFPB : L''Encéphale publie régulièrement des comptes rendus de l''Association française de psychiatrie clinique.